Why Switch? Compare Wegovy vs Mounjaro Benefits & Pricing
Understanding The Mounjaro To Wegovy Transition Process
Changing from Mounjaro to Wegovy involves transitioning from tirzepatide (a dual GIP+GLP-1 receptor agonist) to semaglutide (a selective GLP-1 receptor agonist). This switch requires careful clinical consideration, as both are prescription-only medicines with different mechanisms of action and dosing schedules. Many patients consider this transition due to individual response variations, side effect profiles, or practical considerations like storage requirements.
The process of changing from Mounjaro to Wegovy through EverydayMeds begins with our comprehensive 3-minute clinical assessment, where our prescribers evaluate your current treatment response and medical history. Our GPhC-registered pharmacy (#9012878) ensures seamless transition support, with new customers benefiting from discount code FIRST40 and returning customers using DOSE25, both applied at checkout for immediate savings.
Wegovy Pricing Structure & Discount Code Application
When changing from Mounjaro to Wegovy, understanding the pricing structure helps plan your transition budget effectively. Wegovy's dose escalation begins at £79.99 for the 0.25mg starter dose (weeks 1-4), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. These prices reflect the discount already applied through codes FIRST40 (new customers) or DOSE25 (returning customers) at checkout.
Our bundle options provide convenience for patients changing from Mounjaro to Wegovy who prefer fewer orders and Reliable Supply continuity. The Intro Trio bundle (0.25mg, 0.5mg, and 1mg) costs £299.99, providing your first three months of treatment in one delivery. For maintenance patients, the Consistency 2.4mg bundle (two pens) at £419.99 ensures uninterrupted treatment supply with temperature-controlled storage throughout delivery.
Clinical Evidence Supporting The Mounjaro To Wegovy Switch
Patients changing from Mounjaro to Wegovy should understand both treatments' clinical foundations. The STEP trial programme demonstrated semaglutide's efficacy, with STEP 1 showing approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial further showed a 20% reduction in major cardiovascular events among adults with established cardiovascular disease.
While direct head-to-head comparisons between Mounjaro and Wegovy aren't available due to different trial designs and populations, both treatments have shown substantial efficacy in their respective clinical programmes. Your prescriber can evaluate which treatment may be more suitable based on your individual medical history, current response, and treatment goals when considering this transition.
How Wegovy Works Differently From Mounjaro
Wegovy contains semaglutide, a selective GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1 produced in your intestine. This mechanism differs from Mounjaro's dual action, as Wegovy focuses specifically on GLP-1 pathways to reduce appetite and promote satiety. The medication works by slowing gastric emptying, which helps you feel fuller for longer after meals, and acts on brain appetite centres to reduce food cravings. Wegovy also influences glucose-dependent insulin secretion, though this effect is secondary to its primary weight management indication. This targeted GLP-1 approach may suit patients who experienced specific side effects with Mounjaro's dual receptor activation or those seeking a different mechanism of action.
Streamlined Ordering Process For Treatment Transition
Changing from Mounjaro to Wegovy through EverydayMeds involves a straightforward three-step process designed for treatment continuity. Our online clinical assessment takes just 3 minutes and captures your current treatment history, including your Mounjaro experience, dosing, and any side effects or concerns. Once submitted, our prescribers typically review assessments within 3 working days (or 24 hours with express review), evaluating your suitability for Wegovy based on MHRA licensing criteria and clinical guidelines. Upon approval, your Wegovy prescription ships via next-day delivery using temperature-controlled packaging to maintain the cold chain throughout transit. This efficient process minimises treatment gaps when transitioning between medications, with our pharmacy team available to answer questions throughout your switch.
Storage Advantages When Changing From Mounjaro To Wegovy
One practical benefit of changing from Mounjaro to Wegovy is the superior storage flexibility that semaglutide offers. Wegovy can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy more convenient for travel, work situations, or households where refrigerator space is limited. Both medications require refrigeration (2-8°C) for optimal long-term storage, but Wegovy's FlexTouch pen design combined with its temperature tolerance provides greater flexibility for active lifestyles. The dose escalation follows a structured 4-week schedule: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards.
Transition Timeline And Practical Considerations
The timing of changing from Mounjaro to Wegovy requires coordination with your prescriber to ensure appropriate washout periods and dose initiation. Unlike switching between doses of the same medication, transitioning between different GLP-1 treatments may involve starting Wegovy at the initial 0.25mg dose regardless of your previous Mounjaro dose. This restart approach allows your system to adjust to semaglutide's specific pharmacokinetics and helps minimise potential gastrointestinal side effects during the transition.
Planning your transition also involves considering prescription timing and delivery logistics to avoid treatment gaps. EverydayMeds' next-day delivery service helps maintain treatment continuity, while our clinical team can advise on optimal timing for starting Wegovy after discontinuing Mounjaro. Remember to apply discount codes FIRST40 (new customers) or DOSE25 (returning customers) at checkout to access our competitive pricing throughout your transition period.
Complete Your Mounjaro To Wegovy Switch With EverydayMeds
Ready to explore changing from Mounjaro to Wegovy? Our streamlined process makes this transition as smooth as possible, with competitive pricing, expert clinical oversight, and reliable delivery ensuring continuity of care. New customers benefit from discount code FIRST40, while returning patients use code DOSE25, both applied automatically at checkout for immediate savings. Start your clinical assessment today at https://everydaymeds.co.uk/collections/wegovy or contact our clinical team for personalised guidance on your treatment transition. Our commitment extends beyond dispensing — we provide ongoing support throughout your weight management journey. With GPhC registration #9012878, temperature-controlled delivery, and comprehensive clinical assessment, EverydayMeds ensures your Mounjaro to Wegovy transition meets the highest pharmaceutical standards.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
